Budget 2023 may offer Research Linked Incentive scheme for Indian pharma
RLI is expected to provide an extra financial cushion, in addition to the existing R&D sops available to pharmaceutical and biotech companies operating in India.
pharma industry
January 2023
September 2022
August 2022
January 2022
December 2021
Surprise! Despite Covid-19 sales, Indian pharma an underperformer
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
Sluggish exports to hit pharma revenue growth: CRISIL
The domestic formulations market is expected to grow 7-9% this fiscal.
Predictions 2022: Year of personalisation of healthcare and therapies
2022 will be the year of incubation for technological advancements that will shape the personalisation of healthcare and therapies for the next five decades.
Predictions 2022: The pandemic and beyond: How the pharma industry is shaping up for the future
In the coming year, the pharma industry will continue to reimagine itself while driving growth and boosting value.
